SCHEMBL6267129

SCHEMBL6267129

O=C(O)c1ccc(OCC2CC(=O)N(c3ccc(Oc4ccc(Cl)cc4)cc3)C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
TP53 P04637 1/20 0.53
RAB9A P51151 3/20 0.50
KMT2A Q03164 3/20 0.50
NPC1 O15118 2/20 0.50
HPGD P15428 2/20 0.48
FFAR1 O14842 1/20 0.48
ALDH1A1 P00352 3/20 0.46
ENPP2 Q13822 1/20 0.46
GLA P06280 1/20 0.45
POLB P06746 1/20 0.45
NR4A2 P43354 1/20 0.44
CMA1 P23946 1/20 0.44
GRM2 Q14416 1/20 0.44
MEN1 O00255 2/20 0.43
LTA4H P09960 2/20 0.43
MGLL Q99685 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6267362 0.97 LMNA (0.55) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6272688 0.91 ALDH1A1 (0.48) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6269907 0.91 RAB9A (0.63) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6271374 0.89 LMNA (0.55) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6267665 0.87 CMA1 (0.48) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6266719 0.86 ALDH1A1 (0.45) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6271800 0.86 GLA (0.46) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6265407 0.86 TP53 (0.48) TP53RAB9AKMT2AALDH1A1GLA
SCHEMBL6269058 0.86 LMNA (0.53) LMNATP53RAB9AKMT2ANPC1
SCHEMBL6269794 0.86 LMNA (0.48) LMNATP53RAB9AKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000620-B1 Lp(a)-LOWERING AGENTS AND APOPROTEIN (a) PRODUCTION INHIBITORS TAIHO PHARMACEUTICAL CO LTD (JP) 2005-12-07 EP disclosed
US-6166036-A Lp(a)-lowering agent and apolipoprotein (a) formation suppressing agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-1000620-A1 Lp(a)-LOWERING AGENTS AND APOPROTEIN (a) PRODUCTION INHIBTORS TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 2000-05-17 EP disclosed
EP-0393607-B1 Phenylcarboxylic acid derivatives having a hetero ring OTSUKA PHARMA CO LTD (JP) 1996-02-21 EP disclosed
US-5145865-A Fatty acid, cholesterol synthesis inhibitors; enzyme inhibitors; antilipemic agents OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1992-09-08 US disclosed
EP-0393607-A2 Phenylcarboxylic acid derivatives having a hetero ring OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-10-24 EP disclosed